A Randomized Phase 2 Study of Erenumab for the Prevention of Episodic Migraine in Japanese Adults

OBJECTIVE: A phase 2, double‐blind, placebo‐controlled study to evaluate the efficacy and safety of erenumab for the prevention of episodic migraine in Japanese patients was conducted. BACKGROUND: Previous global clinical studies have demonstrated the efficacy of erenumab in the prevention of migrai...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakai, Fumihiko, Takeshima, Takao, Tatsuoka, Yoshihisa, Hirata, Koichi, Lenz, Robert, Wang, Yi, Cheng, Sunfa, Hirama, Toshiyasu, Mikol, Daniel D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900095/
https://www.ncbi.nlm.nih.gov/pubmed/31612482
http://dx.doi.org/10.1111/head.13652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900095/
https://www.ncbi.nlm.nih.gov/pubmed/31612482
http://dx.doi.org/10.1111/head.13652

Ejemplares similares